![Grant Bogle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Grant Bogle
Direktor/Vorstandsmitglied bei
NUVALENT, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Grant C.
Bogle is currently Director at Gladius Therapeutics, Inc., Director at Myrobalan Therapeutics, Inc., Director at American School for the Deaf, and Independent Director at Nuvalent, Inc. since 2024.
Former roles include President, Chief Executive Officer, CFO & Director at Epizyme, Inc. from 2021 to 2022; Principal at EIDP, Inc., Roche Pharmaceuticals, Inc., Abbott India Ltd., and American Hospital Supply Corp.; Senior Vice President-Sales & Marketing at Millennium Pharmaceuticals, Inc.; EVP-Strategy & Emerging Businesses at US Oncology, Inc. from 2010 to 2011; Executive VP-Integrated Oncology Solutions at US Oncology Holdings, Inc.; Chief Commercial Officer & Senior Vice President at Tesaro, Inc. from 2015 to 2019; and Senior VP-Pharmaceutical & Biotech Solutions at McKesson Specialty Health, Inc. Education includes an MBA from The Trustees of Columbia University in The City of New York and undergraduate studies at Dartmouth College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,01 % | 16.06.2026 | 9.291 ( 0,01 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Grant Bogle
| Unternehmen | Position | Beginn |
|---|---|---|
| NUVALENT, INC. | Direktor/Vorstandsmitglied | 09.12.2024 |
Gladius Therapeutics, Inc.
 Gladius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Direktor/Vorstandsmitglied | - |
Myrobalan Therapeutics, Inc.
 Myrobalan Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech firm that develops therapeutic solutions for central nervous system disorders | Direktor/Vorstandsmitglied | - |
American School for the Deaf
 American School for the Deaf Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Grant Bogle
| Unternehmen | Position | Ende |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 22.01.2019 |
| EPIZYME, INC. | Vorstandsvorsitzender | - |
McKesson Specialty Health, Inc.
 McKesson Specialty Health, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Corporate Officer/Principal | - |
American Hospital Supply Corp.
 American Hospital Supply Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells lines of medical care products | Corporate Officer/Principal | - |
US Oncology Holdings, Inc.
 US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services Operates as a holding company | Corporate Officer/Principal | - |
Ausbildung von Grant Bogle
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
EIDP, Inc.
 EIDP, Inc. Chemicals: AgriculturalProcess Industries Manufactures and sells seed & crop protection products | Process Industries |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
US Oncology, Inc.
 US Oncology, Inc. Hospital/Nursing ManagementHealth Services Provides cancer treatment services | Health Services |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
US Oncology Holdings, Inc.
US Oncology Holdings, Inc. Medical/Nursing ServicesHealth Services Operates as a holding company | Health Services |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbott India Ltd.
 Abbott India Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, diagnostic, nutritional and hospital products | Health Technology |
American Hospital Supply Corp.
American Hospital Supply Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells lines of medical care products | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
American School for the Deaf
American School for the Deaf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McKesson Specialty Health, Inc.
McKesson Specialty Health, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Gladius Therapeutics, Inc.
Gladius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Myrobalan Therapeutics, Inc.
Myrobalan Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech firm that develops therapeutic solutions for central nervous system disorders | Health Technology |
Wählen Sie MarketScreener 
